Hi everyone! I am so excited to start grad school next fall but am faced with a really tough decision!! I am really interested in cancer biology, and would study a wide range of topics within the field. I am deciding between gerstner Sloan Kettering and MIT! Both schools have lots of faculty I am interested in so its difficult to decide, and as you can see I can't seem to think of many cons to either- so I could really use some advice! Here are some pros and cons I came up with:
GSK: More translational research, biomedical focus, Manhattan, awesome housing, clinical program, also has cancer immunology
MIT: Its MIT, in the center of biotech, broader training, Boston, collaborative across many disciplines, I am interested potentially in doing a some what computationally related project and they have many cancer biologists who do this, an especially intense/intellectually stimulating environment
GSK: very cancer bio focused, newer program
MIT: Lack of cancer immunology, kind of want to leave boston
Thanks so much in advance!